Records containing: Influenza, Human
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-09-06A Phase IA/IB Trial to Evaluate the Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) With Hemagglutinin Dose Escalation Compared to Non-Adjuvanted Comparator Inactivated Influenza Vaccine (IIV) Standard Dose (SD) in Healthy Adults and High Dose (HD) IIV in Ambulatory Elderly Subjects
-
CLINICAL_TRIALS study record update · 2019-08-29Can Uptake of Childhood Influenza Immunisation in GP Practices be Increased Through Behavioural-insight Informed Changes to the Invitation Process?
-
CLINICAL_TRIALS study record update · 2019-08-05Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
-
CLINICAL_TRIALS study record update · 2019-07-22A Phase 2/3 Double Blinded, Randomized, Placebo-Controlled Study in Healthy Adult Volunteers in Vietnam to Examine the Safety and Immunogenicity of a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine (IVACFLU-S) Produced by IVAC
-
CLINICAL_TRIALS study record update · 2019-06-05Centralized IIS-Based Reminder Recall to Increase Influenza Vaccination Rates in New York State - Second Trial in New York State
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-05-15An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe
-
CLINICAL_TRIALS study record update · 2019-02-21A Phase I/II, Randomised, Placebo-controlled, Partially-blinded, Parallel-group Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU
-
CLINICAL_TRIALS study record update · 2019-02-11Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
-
CLINICAL_TRIALS study record update · 2019-02-05A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults
-
CLINICAL_TRIALS study record update · 2019-01-28A Phase 1 Double Blinded, Randomized, Placebo-Controlled Study In Healthy Adult Volunteers In Vietnam To Examine The Safety And Immunogenicity Of A Seasonal Trivalent Inactivated Split Virion Influenza Vaccine (IVACFLU-S) Produced By IVAC
-
CLINICAL_TRIALS study record update · 2019-01-23A Phase 3, Randomized, Multicenter, Observer-blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) With a US-licensed Quadrivalent Inactivated Comparator Influenza Virus Vaccine (Comparator QIV) in a Pediatric Population 6 Months Through 59 Months of Age
-
CLINICAL_TRIALS study record update · 2019-01-16Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (2018 Southern Hemisphere Season) Produced at Butantan Institute
-
CLINICAL_TRIALS study record update · 2019-01-15A Phase 1 Double Blinded, Randomized, Placebo-Controlled Study to Examine the Safety and Immunogenicity of a Seasonal Trivalent Split, Inactivated Influenza Vaccine Produced by Torlak in Healthy Adult Volunteers in Serbia
-
CLINICAL_TRIALS study record update · 2019-01-10Nudging for Vaccination : Efficacity and Acceptability Among Medical Students
-
CLINICAL_TRIALS study record update · 2019-01-04Open-labeled(Part 1), Single-group(Part 2), Randomized(Part 2), Double-blind(Part 2), Active-controlled(Part 2) Pharse II Clinical Trial to Evaluate Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
-
CLINICAL_TRIALS study record update · 2018-11-19Randomized, Single-Blind, Active Comparator-controlled Study to Evaluate the Safety and Immunological Efficacy of GC3114 in Healthy Adults.
-
CLINICAL_TRIALS study record update · 2018-09-28A Randomized, Double-blind, Active Comparator, Phase I/Ⅱa Clinical Trial to Assess the Safety and Immunogenicity of the 'IL-YANG Flu Vaccine Quadrivalent Inj.' in Healthy Korean Adult Subjects
-
CLINICAL_TRIALS study record update · 2018-07-26A Phase I/II, Two-Staged, Single-Center, Randomized, Double-Blind, Antibody Titer Study to Assess Immunogenicity and Safety of FluMist® Intranasal Influenza Vaccine Administered With and Without a TLR-3 Agonist, Ampligen®.
-
CLINICAL_TRIALS study record update · 2018-07-12A Double-Blind, Randomized, Stratified Multi-Center Trial Evaluating Conventional and Double Dose Oseltamivir in the Treatment of Immunocompromised Patients With Influenza
-
CLINICAL_TRIALS study record update · 2018-05-15Comparative Tests of Flu Vaccination Phone Messages
-
CLINICAL_TRIALS study record update · 2018-04-18The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study
-
CLINICAL_TRIALS study record update · 2018-04-04Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers
-
CLINICAL_TRIALS study record update · 2018-02-22An Open-label, Multi-centre, Single Arm Study to Evaluate the Safety and Efficacy of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Confirmed Influenza Infection (NAI115215)
-
CLINICAL_TRIALS study record update · 2018-02-06Clinical Performance of the Diassess Influenza A and B Test
-
CLINICAL_TRIALS study record update · 2017-11-30Inactivated Influenza Via Jet Injection